Case Report
On Two Cases with Autosomal Dominant Hyper IgE Syndrome: Importance of Immunological Parameters for Clinical Course and Follow-Up
Table 4
Serum levels of cytokines investigated in Patients 1 and 2.
| Cytokine | Concentration (pg/ml) | | | Patient 1 | Patient 2 | Reference range | At the time of diagnosis, without prophylactic treatment | After 2 y of prophylactic treatment | At the time of diagnosis, without prophylactic treatment | After 4 y of prophylactic treatment | After 5 y of prophylactic treatment | After 6 y of prophylactic treatment | |
| IFN-gamma | 143.85 | 14.5 | 244.37 | 6.47 | 17.75 | 3.92 | 8.08 ± 25.32 | IL-12p70 | 54.46 | 0.0 | 50.96 | 2.83 | 2.63 | 0.0 | 0.90 ± 1.26 | IL-13 | 1.17 | 0.0 | 3.81 | 0.0 | 0.70 | 0.56 | 0.09 ± 0.26 | IL1beta | 1.76 | 0.0 | 47.04 | 1.32 | 1.76 | 0.0 | 0.09 ± 0.23 | IL-2 | 0.0 | 0.0 | 404.17 | 0.87 | 7.93 | 0.0 | 0.57 ± 1.41 | IL-4 | 8.42 | 0.0 | 217.52 | 0.0 | 6.59 | 0.0 | 0.0 | IL-5 | 1.22 | 0.0 | 10.39 | 0.0 | 0.61 | 0.0 | 0.94 ± 1.26 | IL-6 | 25.71 | 0.0 | 18.46 | 1.70 | 1.70 | 3.12 | 0.07 ± 0.24 | TNF-alpha | 2.09 | 0.0 | 9.64 | 0.0 | 6.26 | 4.17 | 0.08 ± 0.28 | GM-CSF | 5.11 | 0.0 | 31.46 | 0.0 | 23.39 | 0.0 | 0.64 ± 1.34 | IL-18 | 113.32 | 16.0 | 43.61 | 22.4 | 43.52 | 4.53 | 1.67 ± 1.75 |
|
|
The values are laboratory specific based on healthy controls tested. |